1. Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
   Bartosz Mateusz Gąsiorkiewicz et al, 2021, Investigational New Drugs CrossRef
2. Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo
   Gaojie Song et al, 2022, Investigational New Drugs CrossRef
3. Screening Multidrug Resistance Reversal Agents in Traditional Chinese Medicines by Efflux Kinetics of D-Luciferin in MCF-7/DOXFluc Cells
   Yue Zhao et al, 2023, ACS Omega CrossRef
4. Icariin inhibits cisplatin-induced ovarian toxicity via modulating NF-κB and PTEN/AKT/mTOR/AMPK axis
   Basma G. Eid et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
5. The frequency of epithelial ovarian cancer subtypes in Sudanese women at Omdurman Maternity Hospital, 2013-2018: A cross-sectional study
   Rawia Eljaili Elmassry et al, 2019, F1000Research CrossRef
6. Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine
   Zixian Liu et al, 2024, International Journal of Nanomedicine CrossRef
7. Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma
   Yang Yang et al, 2020, BioMed Research International CrossRef
8. Cancer-Related Therapeutic Potential of Epimedium and Its Extracts
   Jipeng Ding et al, 2024, Nutrition and Cancer CrossRef
9. Icariin as a potential anticancer agent: a review of its biological effects on various cancers
   Fang-Yuan Liu et al, 2023, Frontiers in Pharmacology CrossRef